Early Aggressive Therapy Pays Off in Juvenile Arthritis - Medscape

Early Aggressive Therapy Pays Off in Juvenile Arthritis Medscape The benefit of early aggressive treatment has been demonstrated in adults with rheumatoid arthritis, but until now, few studies have focused on children. An estimated 300000 children in the United States have been diagnosed with JIA. Polyarticular JIA ...

Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical ... - MarketWatch (press release)

Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical ... MarketWatch (press release) ENBREL was first approved in the US in 1998 for moderate to severe rheumatoid arthritis and was later approved to treat children and adolescents with moderate to severe juvenile rheumatoid arthritis (now called juvenile idiopathic arthritis) in 1999. ... and more »

Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab ... - MarketWatch (press release)

Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab ... MarketWatch (press release) HUMIRA is used alone, with methotrexate, or with certain other medicines to reduce the signs and symptoms of moderate to severe polyarticular juvenile idiopathic arthritis in children 4 years of age and older. HUMIRA is used to reduce the signs and ... and more »

Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical ... - PR Newswire (press release)

Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical ... PR Newswire (press release) ENBREL was first approved in the US in 1998 for moderate to severe rheumatoid arthritis and was later approved to treat children and adolescents with moderate to severe juvenile rheumatoid arthritis (now called juvenile idiopathic arthritis) in 1999. ... and more »